In fact, the latest anemia guidelines from the Kidney Disease Improving Outcomes (KDIGO) initiative recommend to start treatment with Erythropoiesis-Stimulating Agents (ESA) after correction of iron deficiency, and that iron treatment may be performed also in patients with a normal iron balance to increase Hemoglobin (Hb) levels [4]. This evidence concerns the gene GSTM1 and anemia.